| Application no. and date | 07802348.8 (espacenet) (Federated) (European Patent Register), 20070911 | | Patent/reg. no. and date | DK/EP 2066352, 20151202 | | Publication date | 20090610 | | Priority no. and date | US 844251 P, 20060913, EP 06090169, 20060914 | | EP pub. no. and date |
EP 2066352 20090610 | | Effective date | | | Applicant/owner | Genzyme Corporation, 450 Water Street
CAMBRIDGE, MA 02141 , US,
Alcafleu Management GmbH & Co. KG, Lilienthalstrasse 4
12529 Schönefeld OT Waltersdorf, DE | | Applicant ref. no. | Sanofi US 5380EPEPT1 | | Inventor | MARGOLIN, David Harris, 48 Highland Road
Sommerville, MA 02144, US,
SACHSE, Andreas, Johann-Georg-Strasse 21
10709 Berlin, DE | | Representative | RWS Group, RWS Compass House
Vanwall Business Park, Vanwall Road
Maidenhead, Berkshire
SL6 4UB, GB | | Opponent | | | IPC Class | A61K 39/395 (2006.01) , A61P 25/00 (2006.01) , C07K 16/28 (2006.01) | | Title | BEHANDLING AF MULTIPEL SKLEROSE (MS) MED CAMPATH-1H | | Int. application no. | EP2007008084 | | Int. publication no. | WO2008031626 | | Related patent (certificate) | CA 2016 00026 | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
